LL M22
Pill imprint LL M22 has been identified as Methyldopa 250 MG.
Methyldopa is used in the treatment of hypertensive emergency; high blood pressure and belongs to the drug class antiadrenergic agents, centrally acting. Risk cannot be ruled out during pregnancy.
Methyldopa 250 MG is not subject to the Controlled Substances Act.
See also related documents.
Methyldopa Images
- Imprint:
-
LL
M22 - Strength:
- 250 MG
- Color:
- Orange
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Antiadrenergic agents, centrally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Lederle Laboratories
Advertisement
More METHYLDOPA resources
- Methyldopa (Wolters Kluwer)
- Methyldopate (Wolters Kluwer)
- methyldopa (Cerner Multum)
- methyldopa Oral, Intravenous (Micromedex) - Includes Dosage Information
- Methyldopa (AHFS DI)
- methyldopate hydrochloride (AHFS DI)
- Methyldopa (FDA)
- Methyldopate (FDA)
- Methyldopa and Methyldopate Hydrochloride (Wolters Kluwer)
Search Again
